Bronchial Hyperreactivity During Histamine Passive Exposure
NCT01937494 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13
Last updated 2015-02-23
Summary
Bronchial hyperresponsiveness consists in excessive response to bronchial stimuli.Bronchial challenge test is used to confirm/exclude asthma (metacholine or histamine).Protection are used to avoid passive exposure of the technicians performing the test, despite the absence of evidence that they could develop a bronchoconstriction even if they suffer from BHR.The purpose of the study is to determine if patients with a high level of bronchial hyperreactivity and exposed passively to histamine during a bronchial challenge, are developing a bronchoconstriction, when placed in the same conditions that the technicians performing these tests.
Conditions
- Asthma
- Bronchial Hyperresponsiveness
Interventions
- DRUG
-
histamine-benzylic alcohol (magistral preparation)
passive exposure to histamine during a bronchial hyperresponsiveness challenge
Sponsors & Collaborators
-
Centre Hospitalier Universitaire Saint Pierre
lead OTHER
Principal Investigators
-
Marie Bruyneel, MD · CHU ST Pierre
Study Design
- Allocation
- NA
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-05-31
- Primary Completion
- 2014-05-31
- Completion
- 2014-05-31
Countries
- Belgium
Study Locations
More Related Trials
-
Multicentric, Transversal, Descriptive, Epidemiological Study on the Management of Asthma in Asthmatic Middle East Adult Population
NCT02153411 ·Status: COMPLETED
-
Adequacy of Management of Patients With Asthma Exacerbation in Martinique
NCT05253391 ·Status: UNKNOWN
-
A Study to Assess the Potential for Airway Sensitivity Reactions With Propellants HFA-152a (Test) and HFA-134a (Reference) Administered Via Pressurized Inhalers in Adults With Mild Asthma
NCT06702462 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess and Compare Safety and Tolerability of 3 Months Treatment With Salbutamol Administered Via MDI Containing Propellant HFA-152a or HFA-134a in Participants ≥ 18 Years of Age With Asthma
NCT06261957 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Daily Dosing With Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects With Asthma
NCT00073814 ·Status: COMPLETED ·Phase: PHASE3
-
Anti-histamines and Methacholine Challenges.
NCT01985789 ·Status: COMPLETED ·Phase: PHASE4
-
Down-titration of Steroids in Patients With Difficult Asthma With no Bronchial Hyperreactivity
NCT03321877 ·Status: COMPLETED ·Phase: NA
-
Extra-fine Formoterol/Beclomethasone in Asthmatic Crisis
NCT02345993 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effect of Benralizumab on Exercise-induced Bronchoconstriction
NCT03327701 ·Status: UNKNOWN ·Phase: PHASE3
-
Nebulized Beclomethasone Dipropionate Improves Respiratory Lung Function in Preschool Children With Recurrent Wheezing
NCT02381158 ·Status: COMPLETED ·Phase: PHASE4
-
Salbutamol Tolerance Onset
NCT01338311 ·Status: COMPLETED ·Phase: PHASE4
-
Methacholine Challenge Test in School Children With/Without Asthma RISKA
NCT07031102 ·Status: RECRUITING
-
Regular Use Effect of Inhaled Ipratropium Bromide on Airway Responsiveness to Methacholine in Well-controlled Asthma
NCT04167280 ·Status: COMPLETED ·Phase: PHASE4
-
Study Evaluating Etanercept in Moderate to Severe Asthma
NCT00141791 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Assess Bronchospasm Potentially Induced by Next-Generation Propellant vs HFA Propellant in an MDI in Participants With Well/Partially Controlled Asthma
NCT05850494 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Compare the Relative Potency of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152a to HFA-134a in Mild Asthmatics Aged 18 to 65 Inclusive
NCT06433921 ·Status: RECRUITING ·Phase: PHASE1
-
Change in Airway Responsiveness After Allergen Exposure
NCT01699594 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Onset of Relief From Methacholine-induced Bronchoconstriction With CHF1535 NEXThaler in Asthmatic Patients.
NCT03108534 ·Status: COMPLETED ·Phase: PHASE2
-
NHFT Effects on Symptatheic Drive of Asthma Patients
NCT05704101 ·Status: COMPLETED
-
Characterization of the Role of Histamine in Children With Asthma
NCT01392859 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Investigation of Efficacy, Safety and Tolerability of Once and Twice Daily Doses of AZD1981 in Asthmatic Patients
NCT01197794 ·Status: COMPLETED ·Phase: PHASE2
-
Dose Response Study of Levalbuterol in the Prevention of Exercise Induced Bronchoconstriction Compared to Racemic Albuterol in Pediatric Subjects
NCT00685347 ·Status: COMPLETED ·Phase: PHASE2
-
Daily Monitoring of Exhaled Nitric Oxide in Asthmatic Patients
NCT01113853 ·Status: COMPLETED
-
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
NCT03084718 ·Status: COMPLETED ·Phase: PHASE2
-
Predictive Factors in Response to Inhaled Corticoids in Chronic Cough
NCT02715167 ·Status: UNKNOWN ·Phase: NA